Exclusive from BIO-Europe 2015: Interview with F-star, a Cambridge-UK Immuno-oncology Biotech

Second interview of BIO-Europe 2015. This time, it’s a British company from Cambridge (UK): F-star. This morning we spoke with their CBO Jane Dancer.

pic-global-header-logo-fstarF-star is developing bi-specific antibodies for immuno-oncology and inflammatory disease. It has raised a total of 38 million euros from top EU VCs. Jane Dancer’s business tenure within the field is impressive, with 5 years at MedImmune and 4 years experience with Cellzome, supported by a PhD and MBA in the life sciences field from the University of Cambridge.

It was great being able to talk with Jane about F-star’s bi-specific antibody platform, the running of their clinical trials and the appointment of a strong management team (to include a new CSO with 20+ years experience at GSK!).


Here’s the interview…

Let's Continue The Conversation

Feel free to send us comments about this article to comments@labiotech.eu and/or comment on that article on social media.

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.